Streetbeat News

Price Targets

OTLK

Guggenheim analyst Eddie Hickman has upgraded Outlook Therapeutics (NASDAQ:OTLK) from Neutral to Buy and set a price target of $2. This upgrade reflects a positive change in the analyst's view of the company's stock potential.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:07 pm

CASH

Keefe, Bruyette & Woods analyst Michael Perito has maintained a 'Market Perform' rating on Pathward Financial (NASDAQ:CASH) and increased the price target from $57 to $60.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:07 pm

FLEX

Goldman Sachs analyst Mark Delaney has maintained a Buy rating on Flex (NASDAQ:FLEX) but has reduced the price target from $34 to $27.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:07 pm

FSR

Goldman Sachs analyst Mark Delaney has maintained a Sell rating on Fisker (NYSE:FSR) and reduced the price target from $1 to $0.75.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:05 pm

BOKF

Keefe, Bruyette & Woods analyst Brady Gailey has maintained a 'Market Perform' rating on BOK Financial (NASDAQ:BOKF) and increased the price target from $92 to $94.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:05 pm

CHPT

Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on ChargePoint Holdings (CHPT) but has reduced the price target from $2.5 to $2.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:03 pm

DD

BMO Capital analyst John McNulty has downgraded DuPont de Nemours (NYSE:DD) from Outperform to Market Perform and reduced the price target from $80 to $72.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:02 pm

APH

Goldman Sachs analyst Mark Delaney has reaffirmed a Buy rating on Amphenol (NYSE:APH) and increased the price target from $107 to $119.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:00 pm

PGR

Progressive (NYSE:PGR) has been evaluated by 11 analysts over the last three months, with a mix of bullish to bearish sentiments. The average 12-month price target for PGR is now $169.09, up 10.6% from the previous target. Analysts from firms like Piper Sandler, UBS, and Wells Fargo have raised their price targets, reflecting a positive outlook. Progressive is a major auto insurer with significant market cap and revenue growth, but faces challenges with net margin and debt management. Its ROE and ROA outperform industry averages.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 2:00 pm

UCBI

Analyst ratings for United Community Banks (NASDAQ:UCBI) show a mix of bullish and indifferent stances, with no bearish ratings over the last quarter. The average 12-month price target is $31.00, a 9.23% increase from the previous target of $28.38. Analysts from Piper Sandler and DA Davidson have raised their price targets, while Truist Securities has raised its target significantly from $25.00 to $32.00. United Community Banks operates a community-focused banking model and has shown positive revenue growth but has below-average net margin, ROE, and ROA compared to the industry.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 2:00 pm